Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 9/15/15 → 12/5/20 |
Financiación
- Rebiotix Inc: 53.325,00 US$
15-ID-200: An Open-label Safety Assessment of Rebiotix RBX2660 (microbiota suspension) for the Treatment of Recurrent Clostridium difficile Infection (PUNCH SOS)
- Greenberg, Richard (PI)